US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioAge Labs Inc.

8.31

+0.51006.54%

Post-market: 8.340.0300+0.36%17:43 EST

Volume:289.01K

Turnover:2.37M

Market Cap:297.96M

PE:-3.94

High:8.36

Open:7.87

Low:7.84

Close:7.80

52wk High:20.37

52wk Low:2.88

Shares:35.86M

Float Shares:24.31M

Volume Ratio:1.53

T/O Rate:1.19%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1117

EPS(LYR):-6.6293

ROE:-25.64%

ROA:-17.46%

PB:1.07

PE(LYR):-1.25

Loading ...

Overview Company News Filings

BioAge Labs to Present at Jefferies Global Healthcare Conference in London

BioAge Labs Advances Clinical Programs Amid Financial Progress

Bioage Labs Q3 EPS $(0.56) Beats $(0.58) Estimate, Sales $2.054M

BioAge Labs Doses First Participant in BGE-102 Phase 1 Trial and Reports $2.1 Million Q3 Collaboration Revenue

Bioage Labs Reports Third Quarter 2025 Financial Results and Provides Business Updates

THOMSON REUTERS

Calendar of U.S. Earnings Expected in the Week Ahead

BIOAGE Labs Inc expected to post a loss of 58 cents a share - Earnings Preview

BioAge Labs Is Maintained at Buy by Citigroup

U.S. RESEARCH ROUNDUP-Avery Dennison, Expedia Group, Hologic

BioAge Labs Shares Rise After Citigroup Upgrade

MT Newswires Live

BioAge Labs Raised to Buy From Neutral by Citigroup

Bioage Labs Shares Jump 7.7% Premarket After Citigroup Upgrade, PT Hike

THOMSON REUTERS

BioAge Labs upgraded to Buy from Neutral at Citi

BRIEF-BioAge Labs Files For Mixed Shelf Offering Of Up To $250 Million - SEC Filing

BioAge Labs Files $250 Million Mixed Shelf

MT Newswires Live

BioAge Labs files $250M mixed securities shelf

Bioage Labs Inc : Files for Mixed Shelf Offering of up to $250 Mln - SEC Filing

THOMSON REUTERS

BioAge Labs, Inc. (NASDAQ:BIOA) institutional owners may be pleased with recent gains after 74% loss over the past year

Simply Wall St.

BioAge Labs Inc. to Participate in Citi's 2025 Biopharma Back to School Conference

BioAge Labs Initiates Phase 1 Clinical Trial for BGE-102, a Brain-Penetrant NLRP3 Inhibitor Targeting Obesity

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BIOA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIOA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOA\",,,,,undefined,":{"symbol":"BIOA","market":"US","secType":"STK","nameCN":"BioAge Labs Inc.","latestPrice":8.31,"timestamp":1763413200000,"preClose":7.8,"halted":0,"volume":289013,"hourTrading":{"tag":"盘后","latestPrice":8.34,"preClose":8.31,"latestTime":"17:43 EST","volume":2735,"amount":22760.571539999997,"timestamp":1763419421905},"delay":0,"floatShares":24308899,"shares":35855037,"eps":-2.111699,"marketStatus":"Post-Mkt","change":0.51,"latestTime":"11-17 18:00:26 EST","open":7.87,"high":8.355,"low":7.84,"amount":2370283.3284454998,"amplitude":0.066026,"askPrice":8.4,"askSize":100,"bidPrice":7.31,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.111699,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1763427600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1727323200000,"exchange":"NASDAQ","adjPreClose":7.8,"preHourTrading":{"tag":"盘前","latestPrice":7.94,"preClose":7.8,"latestTime":"09:28 EST","volume":212,"amount":1700.9402360000001,"timestamp":1763389680010},"postHourTrading":{"tag":"盘后","latestPrice":8.34,"preClose":8.31,"latestTime":"17:43 EST","volume":2735,"amount":22760.571539999997,"timestamp":1763419421905},"volumeRatio":1.533435,"impliedVol":1.3762,"impliedVolPercentile":0.8135},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOA\",,,,,undefined,":{"symbol":"BIOA","floatShares":24308899,"roa":"-17.46%","roe":"-25.64%","lyrEps":-6.629269,"volumeRatio":1.533435,"shares":35855037,"dividePrice":0,"high":8.355,"amplitude":0.066026,"preClose":7.8,"low":7.84,"week52Low":2.88,"pbRate":"1.07","psRate":"50.36","week52High":20.37,"institutionHeld":0,"latestPrice":8.31,"eps":-2.111699,"divideRate":0,"volume":289013,"delay":0,"ttmEps":-2.111699,"open":7.87,"prevYearClose":5.79,"prevWeekClose":7.8,"prevMonthClose":7.57,"prevQuarterClose":5.88,"fiveDayClose":7.49,"twentyDayClose":5.36,"sixtyDayClose":4.61},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIOA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"BIOA","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.56},{"market":"US","date":"2025-08-06","symbol":"BIOA","fiscalQuarterEnding":"2025/06","expectedEps":-0.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.6},{"market":"US","date":"2025-05-06","symbol":"BIOA","fiscalQuarterEnding":"2025/03","expectedEps":-0.52,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-0.36},{"date":"2025-03-20","symbol":"BIOA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":-0.58,"defaultRemindTime":1742500800000,"name":null,"time":"Post Market","dateTimestamp":1742443200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIOA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIOA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0,"hold":0.5,"sell":0.25,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.5,"analysts":4,"updateTime":1761541200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BIOA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BIOA","date":"2025-11-14","current":-3.93522,"percent":0.189474,"low":-14.88445,"twenty":-3.543352,"median":-2.287377,"eighty":-2.091294,"high":-1.532635,"avg":-3.980969,"sd":3.600182,"marketCap":276800885},"quantilePoints":[{"date":"2024-09-27","current":-10.065016,"twenty":-9.996853,"median":-9.894609,"eighty":-9.328936,"marketCap":625601139},{"date":"2024-10-04","current":-11.466752,"twenty":-11.453559,"median":-10.988513,"eighty":-9.962772,"marketCap":712727458},{"date":"2024-10-11","current":-11.290848,"twenty":-11.83725,"median":-11.290848,"eighty":-10.377246,"marketCap":701793959},{"date":"2024-10-18","current":-13.247909,"twenty":-12.852074,"median":-11.505231,"eighty":-10.913754,"marketCap":823437060},{"date":"2024-10-25","current":-13.708907,"twenty":-13.699687,"median":-12.032944,"eighty":-11.062173,"marketCap":852090807},{"date":"2024-10-31","current":-14.198716,"twenty":-13.910593,"median":-12.258321,"eighty":-11.163318,"marketCap":882535413},{"date":"2024-11-08","current":-10.411209,"twenty":-13.841443,"median":-12.631325,"eighty":-11.163318,"marketCap":738550334},{"date":"2024-11-15","current":-9.850761,"twenty":-13.741177,"median":-12.203351,"eighty":-10.879672,"marketCap":698793259},{"date":"2024-11-22","current":-9.318711,"twenty":-13.704297,"median":-11.736106,"eighty":-10.071646,"marketCap":661050728},{"date":"2024-11-29","current":-9.500638,"twenty":-13.685857,"median":-11.456511,"eighty":-9.850761,"marketCap":673956274},{"date":"2024-12-06","current":-9.283336,"twenty":-13.657045,"median":-11.290848,"eighty":-9.500638,"marketCap":658541317},{"date":"2024-12-13","current":-2.319571,"twenty":-13.258776,"median":-11.073716,"eighty":-9.298497,"marketCap":164545707},{"date":"2024-12-20","current":-2.612676,"twenty":-13.247909,"median":-10.411209,"eighty":-9.141838,"marketCap":185337975},{"date":"2024-12-27","current":-2.971476,"twenty":-13.224859,"median":-10.152544,"eighty":-7.606575,"marketCap":210790579},{"date":"2025-01-03","current":-2.809763,"twenty":-13.09117,"median":-10.065016,"eighty":-3.032119,"marketCap":199318983},{"date":"2025-01-10","current":-2.572247,"twenty":-12.858367,"median":-9.894609,"eighty":-2.886577,"marketCap":182470076},{"date":"2025-01-17","current":-2.54698,"twenty":-12.632478,"median":-9.680039,"eighty":-2.714757,"marketCap":180677639},{"date":"2025-01-24","current":-2.678371,"twenty":-12.552115,"median":-9.568861,"eighty":-2.625815,"marketCap":189998311},{"date":"2025-01-31","current":-2.415588,"twenty":-12.247327,"median":-9.318711,"eighty":-2.600547,"marketCap":171356967},{"date":"2025-02-07","current":-2.309464,"twenty":-12.16927,"median":-9.263122,"eighty":-2.51868,"marketCap":163828732},{"date":"2025-02-14","current":-2.284196,"twenty":-12.012055,"median":-9.141838,"eighty":-2.417609,"marketCap":162036295},{"date":"2025-02-21","current":-2.223554,"twenty":-11.928501,"median":-8.818412,"eighty":-2.37516,"marketCap":157734447},{"date":"2025-02-28","current":-2.208393,"twenty":-11.54371,"median":-3.087708,"eighty":-2.319571,"marketCap":156658985},{"date":"2025-03-07","current":-2.269035,"twenty":-11.466752,"median":-2.971476,"eighty":-2.294303,"marketCap":160960833},{"date":"2025-03-14","current":-2.122483,"twenty":-11.446271,"median":-2.893147,"eighty":-2.269035,"marketCap":150564699},{"date":"2025-03-21","current":-2.208204,"twenty":-11.43377,"median":-2.779442,"eighty":-2.233661,"marketCap":157023162},{"date":"2025-03-28","current":-1.956126,"twenty":-11.290848,"median":-2.7188,"eighty":-2.233661,"marketCap":139098143},{"date":"2025-04-04","current":-1.714131,"twenty":-11.203915,"median":-2.693532,"eighty":-2.213447,"marketCap":121890125},{"date":"2025-04-11","current":-1.729255,"twenty":-11.131435,"median":-2.645523,"eighty":-2.198286,"marketCap":122965626},{"date":"2025-04-17","current":-1.890585,"twenty":-11.039085,"median":-2.589935,"eighty":-2.192221,"marketCap":134437638},{"date":"2025-04-25","current":-2.117456,"twenty":-10.879672,"median":-2.54698,"eighty":-2.170997,"marketCap":150570155},{"date":"2025-05-02","current":-2.087206,"twenty":-10.498085,"median":-2.486337,"eighty":-2.155781,"marketCap":148419153},{"date":"2025-05-09","current":-2.073948,"twenty":-10.229442,"median":-2.420641,"eighty":-2.117456,"marketCap":147343652},{"date":"2025-05-16","current":-1.927611,"twenty":-10.158835,"median":-2.377687,"eighty":-2.112406,"marketCap":136947141},{"date":"2025-05-23","current":-2.038626,"twenty":-10.109042,"median":-2.344838,"eighty":-2.086198,"marketCap":144834149},{"date":"2025-05-30","current":-2.008349,"twenty":-10.078276,"median":-2.334731,"eighty":-2.073148,"marketCap":142683147},{"date":"2025-06-06","current":-2.24047,"twenty":-9.99928,"median":-2.314518,"eighty":-2.051746,"marketCap":159174164},{"date":"2025-06-13","current":-2.2657,"twenty":-9.918948,"median":-2.294303,"eighty":-2.064674,"marketCap":160966666},{"date":"2025-06-20","current":-2.215239,"twenty":-9.87707,"median":-2.284196,"eighty":-2.072748,"marketCap":157381662},{"date":"2025-06-27","current":-2.200101,"twenty":-9.785504,"median":-2.271562,"eighty":-2.073948,"marketCap":156306161},{"date":"2025-07-03","current":-2.159732,"twenty":-9.684587,"median":-2.26468,"eighty":-2.075591,"marketCap":153438158},{"date":"2025-07-11","current":-2.361576,"twenty":-9.665383,"median":-2.263661,"eighty":-2.08254,"marketCap":167778173},{"date":"2025-07-18","current":-2.422129,"twenty":-9.609795,"median":-2.271562,"eighty":-2.08404,"marketCap":172080177},{"date":"2025-07-25","current":-2.371668,"twenty":-9.500638,"median":-2.280838,"eighty":-2.084673,"marketCap":168495173},{"date":"2025-08-01","current":-2.220285,"twenty":-9.464253,"median":-2.280838,"eighty":-2.088197,"marketCap":157740162},{"date":"2025-08-08","current":-1.959737,"twenty":-9.314668,"median":-2.269035,"eighty":-2.084673,"marketCap":154872159},{"date":"2025-08-15","current":-2.023247,"twenty":-9.295465,"median":-2.262157,"eighty":-2.074957,"marketCap":159891165},{"date":"2025-08-22","current":-2.041393,"twenty":-9.27525,"median":-2.258928,"eighty":-2.064982,"marketCap":161325166},{"date":"2025-08-29","current":-2.177486,"twenty":-9.225726,"median":-2.244642,"eighty":-2.064982,"marketCap":172080177},{"date":"2025-09-05","current":-2.136658,"twenty":-9.156998,"median":-2.24047,"eighty":-2.068612,"marketCap":168853674},{"date":"2025-09-12","current":-2.227387,"twenty":-9.141838,"median":-2.24047,"eighty":-2.071948,"marketCap":176023681},{"date":"2025-09-19","current":-2.368016,"twenty":-8.95182,"median":-2.24047,"eighty":-2.073948,"marketCap":187137193},{"date":"2025-09-26","current":-2.368016,"twenty":-8.818412,"median":-2.24047,"eighty":-2.073948,"marketCap":187137193},{"date":"2025-10-03","current":-2.676493,"twenty":-8.732502,"median":-2.244642,"eighty":-2.078994,"marketCap":211515218},{"date":"2025-10-10","current":-2.472354,"twenty":-3.102868,"median":-2.258928,"eighty":-2.082165,"marketCap":195382701},{"date":"2025-10-17","current":-2.318115,"twenty":-3.072547,"median":-2.260654,"eighty":-2.08404,"marketCap":183193689},{"date":"2025-10-24","current":-3.606461,"twenty":-3.072547,"median":-2.2657,"eighty":-2.08404,"marketCap":285007794},{"date":"2025-10-31","current":-3.50666,"twenty":-3.483977,"median":-2.271562,"eighty":-2.087206,"marketCap":277120786},{"date":"2025-11-07","current":-3.533398,"twenty":-3.483977,"median":-2.280838,"eighty":-2.091294,"marketCap":267799776},{"date":"2025-11-14","current":-3.65216,"twenty":-3.543352,"median":-2.287377,"eighty":-2.091294,"marketCap":276800885}],"updateTime":1763420418511},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIOA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2581886318","title":"BioAge Labs to Present at Jefferies Global Healthcare Conference in London","url":"https://stock-news.laohu8.com/highlight/detail?id=2581886318","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581886318?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:00","pubTimestamp":1762524021,"startTime":"0","endTime":"0","summary":"BioAge Labs Inc., a clinical-stage biotechnology company focused on developing therapies for metabolic diseases targeting the biology of human aging, will present at the Jefferies Global Healthcare Conference in London from November 17-20, 2025. CEO Kristen Fortney and CFO Dov Goldstein are scheduled to participate in a fireside chat on November 17 and will join one-on-one meetings during the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioage Labs Inc. published the original content used to generate this news brief via GlobeNewswire  on November 07, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL89BVZr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4112","IE00B64PRP62.GBP","BIOA","BK4007","LU2095319765.USD","NDAQ","BK4588","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4585","IE00BGHQF748.EUR","LU0314104364.USD"],"gpt_icon":0},{"id":"2581780190","title":"BioAge Labs Advances Clinical Programs Amid Financial Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2581780190","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581780190?lang=en_us&edition=fundamental","pubTime":"2025-11-07 14:03","pubTimestamp":1762495412,"startTime":"0","endTime":"0","summary":"BioAge Labs, Inc. ( ($BIOA) ) has released its Q3 earnings. Here is a breakdown of the information BioAge Labs, Inc. presented to its investors. Bi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bioage-labs-advances-clinical-programs-amid-financial-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bioage-labs-advances-clinical-programs-amid-financial-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4097","PRGS","BIOA","LU2065732104.USD"],"gpt_icon":0},{"id":"2581046918","title":"Bioage Labs Q3 EPS $(0.56) Beats $(0.58) Estimate, Sales $2.054M","url":"https://stock-news.laohu8.com/highlight/detail?id=2581046918","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581046918?lang=en_us&edition=fundamental","pubTime":"2025-11-07 06:05","pubTimestamp":1762466746,"startTime":"0","endTime":"0","summary":"Bioage Labs (NASDAQ:BIOA) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.58) by 3.45 percent. This is a 91.64 percent increase over losses of $(6.70) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48706450/bioage-labs-q3-eps-0-56-beats-0-58-estimate-sales-2-054m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Bioage Labs Q3 EPS $(0.56) Beats $(0.58) Estimate, Sales $2.054M","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USAW.SI","NVIW.SI",".IXIC","PSQ","USJW.SI","QID","SQQQ","NQmain","QLD","MNQmain","TSYW.SI","BIOA","TQQQ","BK4007"],"gpt_icon":0},{"id":"2581045158","title":"BioAge Labs Doses First Participant in BGE-102 Phase 1 Trial and Reports $2.1 Million Q3 Collaboration Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2581045158","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581045158?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:48","pubTimestamp":1762465725,"startTime":"0","endTime":"0","summary":"BioAge Labs Inc., a clinical-stage biopharmaceutical company focused on therapies targeting metabolic diseases and human aging, reported its third quarter 2025 financial results and provided business updates. The company announced the dosing of the first participant in its Phase 1 trial of BGE-102, an oral CNS-penetrant NLRP3 inhibitor, with initial single ascending dose data expected by the end of the year. BioAge also continued progress on its oral and parenteral APJ agonist programs, targeting investigational new drug  submissions in 2026. Collaboration revenue for the quarter ended September 30, 2025, was $2.1 million, compared to no revenue in the same period of 2024. This increase was attributed to revenue recognized under BioAge's multi-year research collaboration with Novartis, initiated in 2025. As of September 30, 2025, the company reported approximately $295.9 million in cash, cash equivalents, and marketable securities, which it estimates will be sufficient to fund operatio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDLbGdmn6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU2210150020.SGD","IE00BGHQF748.EUR","LU0314104364.USD","NDAQ","BK4588","LU2095319765.USD","IE00B3QW5Z07.USD","BIOA","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4112","LU2210149790.SGD","BK4585"],"gpt_icon":0},{"id":"2581004559","title":"Bioage Labs Reports Third Quarter 2025 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2581004559","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581004559?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:45","pubTimestamp":1762465500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nTUA91RKJL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2581065756","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2581065756","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581065756?lang=en_us&edition=fundamental","pubTime":"2025-11-06 19:00","pubTimestamp":1762426800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·A-Mark Precs Mtl                                1Q       .60    4:05 PM. ·Achve Life Scncs                                3Q      (.24)   7:30 AM. ·Air Pdts and Chem                                4Q      3.38    6:00 AM. ·Alpha Metall Rsrcs                               3Q      (.52)   7:30 AM. ·Altice USA Inc.                                 3Q      (.06)   7:00 AM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARL","AVAH","AEE","AHR","AMR","AORT","ADVM","AKAM","BIRD","ABNB","ARLO","ALRM","OPTU","ADV","ATUS","BLZE","AMN","ATLC","AMTX","ATYR","BIOA","ASPN","AMLX","ALLO","AMBQ","APPN","ABCL","AAON","ACIW","AFRM","AAOI","APD","APLT","ALTG","GOOS","ACRV","ASMB","ALT","APYX","ASTH","AGO","ACHV","AMRK","ATHM","ABL","ALG","AMPX","ARHS","AMPH","AURA"],"gpt_icon":1},{"id":"2581354701","title":"BIOAGE Labs Inc  expected to post a loss of 58 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2581354701","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581354701?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:06","pubTimestamp":1762376782,"startTime":"0","endTime":"0","summary":"BIOAGE Labs Inc  expected to post a loss of58cents a share - Earnings Preview BIOAGE Labs Inc BIOA.OQ BIOA.O is expected to  show a rise in quarterly revenue when it reports  results on November 7 (es","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nL8N3WH379:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2579557133","title":"BioAge Labs Is Maintained at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2579557133","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579557133?lang=en_us&edition=fundamental","pubTime":"2025-10-30 04:06","pubTimestamp":1761768360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BIOA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 29, 2025 16:06 ET (20:06 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA"],"gpt_icon":0},{"id":"2577666373","title":"U.S. RESEARCH ROUNDUP-Avery Dennison, Expedia Group, Hologic","url":"https://stock-news.laohu8.com/highlight/detail?id=2577666373","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577666373?lang=en_us&edition=fundamental","pubTime":"2025-10-23 15:30","pubTimestamp":1761204653,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Avery Dennison, Expedia Group, Hologic Oct 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aver","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nL8N3W40G6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","LU2357125470.USD","ALKS","IDYA","T","NTRS","GEV","LVS","AVY","BKNG","FULT","HOLX","LU1815336760.USD","BSX","CBU","CPRI","NRIX","RL","HLT","EXPE","LU2023250843.SGD","BHB","KREF","CCI","DECK","ELV","MBCN","LC","LU2125909247.SGD","LU2023250504.SGD","CME","FI","LRCX","BK4150","BIOA","GPOR","APH","GPC","GSHD","IE00BJJMRZ35.SGD","LII","LU1861217088.USD","MOS","OFG","ARCT","FRPT","DKNG","IE00BZ1G4Q59.USD","LU0477156797.USD","JAZZ"],"gpt_icon":0},{"id":"2577986318","title":"BioAge Labs Shares Rise After Citigroup Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2577986318","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577986318?lang=en_us&edition=fundamental","pubTime":"2025-10-23 02:39","pubTimestamp":1761158351,"startTime":"0","endTime":"0","summary":"BioAge Labs  shares were up over 13% in recent Wednesday trading after Citigroup upgraded the stock to buy from neutral and boosted its price target to $10 from $5.Trading volume stood at more than 1.0 million shares, compared with a daily average of about 167,000.Price: 6.00, Change: +0.70, Percent Change: +13.21","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIOA"],"gpt_icon":0},{"id":"2577910366","title":"BioAge Labs Raised to Buy From Neutral by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2577910366","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577910366?lang=en_us&edition=fundamental","pubTime":"2025-10-22 19:31","pubTimestamp":1761132660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BIOA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 22, 2025 07:31 ET (11:31 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA"],"gpt_icon":0},{"id":"2577350984","title":"Bioage Labs Shares Jump 7.7% Premarket After Citigroup Upgrade, PT Hike","url":"https://stock-news.laohu8.com/highlight/detail?id=2577350984","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577350984?lang=en_us&edition=fundamental","pubTime":"2025-10-22 18:14","pubTimestamp":1761128095,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nFWN3W228J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2577354044","title":"BioAge Labs upgraded to Buy from Neutral at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2577354044","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577354044?lang=en_us&edition=fundamental","pubTime":"2025-10-22 17:10","pubTimestamp":1761124209,"startTime":"0","endTime":"0","summary":"Citi upgraded BioAge Labs (BIOA) to Buy from Neutral with a price target of $10, up from $5. The firm believes the company’s BGE-102 can become a “...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-upgraded-to-buy-from-neutral-at-citi-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-upgraded-to-buy-from-neutral-at-citi-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA"],"gpt_icon":0},{"id":"2572526624","title":"BRIEF-BioAge Labs Files For Mixed Shelf Offering Of Up To $250 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2572526624","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572526624?lang=en_us&edition=fundamental","pubTime":"2025-10-03 05:58","pubTimestamp":1759442280,"startTime":"0","endTime":"0","summary":"BRIEF-BioAge Labs Files For Mixed Shelf Offering Of Up To $250 Million - SEC FilingOct 2  - BIOAGE Labs Inc BIOA.O:BIOAGE LABS INC : FILES FOR MIXED SHELF OFFERING OF UP TO $250 MILLION - SEC FILINGSource text: [ID:n0001193125-25-228414]Further company coverage: BIOA.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nFWN3VJ0H9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2572250535","title":"BioAge Labs Files $250 Million Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2572250535","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572250535?lang=en_us&edition=fundamental","pubTime":"2025-10-03 05:37","pubTimestamp":1759441036,"startTime":"0","endTime":"0","summary":"BioAge Labs  filed a registration statement Thursday for the potential sale of up to $250 million of securities from time to time in one or more offerings.The securities cover common and preferred stocks, debt securities, warrants, subscription rights, and units.Net proceeds will be used for general corporate purposes.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2572452394","title":"BioAge Labs files $250M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2572452394","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572452394?lang=en_us&edition=fundamental","pubTime":"2025-10-03 04:35","pubTimestamp":1759437307,"startTime":"0","endTime":"0","summary":"16:32 EDT BioAge Labs (BIOA) files $250M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaki...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-files-250m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-files-250m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2572528000","title":"Bioage Labs Inc : Files for Mixed Shelf Offering of up to $250 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2572528000","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572528000?lang=en_us&edition=fundamental","pubTime":"2025-10-03 04:31","pubTimestamp":1759437096,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nFWN3VJ0H9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2570899883","title":"BioAge Labs, Inc. (NASDAQ:BIOA) institutional owners may be pleased with recent gains after 74% loss over the past year","url":"https://stock-news.laohu8.com/highlight/detail?id=2570899883","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570899883?lang=en_us&edition=fundamental","pubTime":"2025-09-27 21:18","pubTimestamp":1758979096,"startTime":"0","endTime":"0","summary":"Key Insights Given the large stake in the stock by institutions, BioAge Labs' stock price might be vulnerable to their...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bioa/bioage-labs/news/bioage-labs-inc-nasdaqbioa-institutional-owners-may-be-pleas","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bioa/bioage-labs/news/bioage-labs-inc-nasdaqbioa-institutional-owners-may-be-pleas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","QQQ","USAW.SI","QLD","PSQ","USJW.SI","BIOA","NQmain","NVIW.SI","TQQQ","MNQmain","QID",".IXIC","TSYW.SI","SQQQ"],"gpt_icon":0},{"id":"2561481948","title":"BioAge Labs Inc. to Participate in Citi's 2025 Biopharma Back to School Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2561481948","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561481948?lang=en_us&edition=fundamental","pubTime":"2025-08-21 04:30","pubTimestamp":1755721813,"startTime":"0","endTime":"0","summary":"BioAge Labs, Inc., a clinical-stage biotechnology company focused on developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, will participate in Citi's 2025 Biopharma Back to School Conference in Boston from September 2-3, 2025. CEO and co-founder Kristen Fortney, PhD, and CFO Dov Goldstein, MD, will participate in a fireside chat on September 3 from 3:15-3:55 PM EDT and engage in one-on-one meetings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioage Labs Inc. published the original content used to generate this news brief via GlobeNewswire  on August 20, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDLb8W6pN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1162221912.USD","LU2456880835.USD","LU0320765646.SGD","LU0477156953.USD","LU2095319765.USD","LU2417539215.USD","LU0130102774.USD","LU0314104364.USD","BK4007","IE00BKPKM429.USD","LU2210150020.SGD","LU1366192091.USD","LU2125154935.USD","LU1791807156.HKD","LU1244550577.SGD","LU0162691827.USD","LU0648001328.SGD","LU1668664300.SGD","LU0310800965.SGD","BK4534","LU1267930227.SGD","LU0052756011.USD","LU0072461881.USD","LU2236285917.USD","LU2125154778.USD","BK4504","NDAQ","LU0130517989.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU0128525689.USD","LU1244550221.USD","IE00BSNM7G36.USD","LU0106831901.USD","LU1244550494.USD","BK4566","LU2462157665.USD","BK4588","LU2360032135.SGD","BK4207","BK4559","LU2210149790.SGD","LU0980610538.SGD","BK4585","BIOA","IE00BGHQF748.EUR","LU1201861249.SGD","LU0098860793.USD","LU0170899867.USD","BK4112"],"gpt_icon":0},{"id":"2559149309","title":"BioAge Labs Initiates Phase 1 Clinical Trial for BGE-102, a Brain-Penetrant NLRP3 Inhibitor Targeting Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2559149309","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559149309?lang=en_us&edition=fundamental","pubTime":"2025-08-15 21:01","pubTimestamp":1755262886,"startTime":"0","endTime":"0","summary":"BioAge Labs Inc., a clinical-stage biotechnology company, has announced the commencement of a Phase 1 clinical trial for BGE-102, an innovative, orally available small molecule inhibitor of NLRP3. This novel inhibitor demonstrates potential for significant brain penetration and is initially being developed for obesity treatment. The study, which marks the first human dosing of BGE-102, aims to evaluate the drug's safety, tolerability, pharmacokinetics, and pharmacodynamics. Preclinical models have shown promising results, highlighting robust weight loss when BGE-102 is used as a monotherapy or in combination with GLP-1 receptor agonists. BioAge Labs anticipates initial data from the study's single ascending dose  phase by the end of 2025. The company plans to conduct a proof-of-concept study in 2026, with top-line results expected by the end of that year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nNDLvR2QQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BKPKM429.USD","NDAQ","IE00B64PRP62.GBP","BK4588","LU2210149790.SGD","BK4585","BK4007","BIOA","IE00B3QW5Z07.USD","BK4112","LU0314104364.USD","LU2095319765.USD","LU2210150020.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}]}}